MeSH term
Frequency | Condition_Probility | Alleles | 13 | 0.0 |
Comparative Study | 12 | 0.0 |
DNA Primers | 2 | 0.0 |
Gene Frequency | 21 | 0.0 |
Genotype | 5 | 0.0 |
Humans | 76 | 0.0 |
Research Support, Non-U.S. Gov't | 28 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
ABO Blood-Group System | 4 | 6.0 |
Disease Susceptibility | 3 | 0.0 |
*Polymorphism, Genetic | 13 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 9 | 0.0 |
*ABO Blood-Group System | 6 | 15.0 |
Infant, Newborn | 6 | 0.0 |
Prospective Studies | 2 | 0.0 |
Animals | 4 | 0.0 |
Polymorphism, Genetic | 12 | 0.0 |
Adult | 20 | 0.0 |
English Abstract | 14 | 0.0 |
Male | 36 | 0.0 |
Middle Aged | 13 | 0.0 |
Female | 36 | 0.0 |
Pregnancy | 4 | 0.0 |
*Rh-Hr Blood-Group System | 2 | 6.0 |
ABO Blood-Group System/immunology | 2 | 8.0 |
Adolescent | 10 | 0.0 |
Aged | 7 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Blood Group Antigens/*genetics | 14 | 13.0 |
Ethnic Groups/*genetics | 5 | 2.0 |
Genetic Markers/genetics | 3 | 0.0 |
Haplotypes | 6 | 0.0 |
Polymorphism, Genetic/genetics | 2 | 0.0 |
Acid Phosphatase/genetics | 2 | 6.0 |
Adenosine Deaminase/genetics | 2 | 9.0 |
Regression Analysis | 2 | 0.0 |
Evaluation Studies | 2 | 0.0 |
Gene Pool | 2 | 25.0 |
Genetic Markers/*genetics | 2 | 1.0 |
Polymorphism, Genetic/*genetics | 2 | 0.0 |
*Genetics, Population | 7 | 1.0 |
Blood Proteins/*genetics | 4 | 2.0 |
Erythrocytes/*enzymology | 4 | 0.0 |
*Gene Frequency | 9 | 1.0 |
*Gene Pool | 2 | 10.0 |
Phenotype | 14 | 0.0 |
Russia | 2 | 2.0 |
European Continental Ancestry Group/*genetics | 4 | 1.0 |
Genetic Markers | 17 | 0.0 |
Hispanic Americans/*genetics | 2 | 10.0 |
Indians, North American/*genetics | 3 | 3.0 |
Marriage | 3 | 13.0 |
Polymorphism, Restriction Fragment Length | 2 | 0.0 |
ABO Blood-Group System/genetics | 6 | 14.0 |
*Genetic Heterogeneity | 2 | 1.0 |
MNSs Blood-Group System/genetics | 2 | 18.0 |
Rh-Hr Blood-Group System/genetics | 3 | 10.0 |
Case-Control Studies | 2 | 0.0 |
Phosphoglucomutase/genetics | 2 | 4.0 |
Transferrin/genetics | 3 | 6.0 |
African Continental Ancestry Group/*genetics | 3 | 1.0 |
Blood Group Antigens/genetics | 6 | 10.0 |
Chromosome Mapping | 8 | 0.0 |
Haptoglobins/genetics | 2 | 4.0 |
Child | 7 | 0.0 |
Child, Preschool | 3 | 0.0 |
Glucosephosphate Dehydrogenase/genetics | 2 | 2.0 |
Infant | 3 | 0.0 |
Indians, South American/*genetics | 2 | 3.0 |
Prognosis | 2 | 0.0 |
Risk Factors | 3 | 0.0 |
ABO Blood-Group System/*genetics | 6 | 12.0 |
*Blood Stains | 2 | 5.0 |
DNA/analysis | 2 | 0.0 |
Molecular Sequence Data | 2 | 0.0 |
Rh-Hr Blood-Group System | 3 | 8.0 |
*Chromosomes, Human, Pair 9 | 2 | 0.0 |
Tuberous Sclerosis/*genetics | 3 | 3.0 |
Blood Proteins/genetics | 4 | 7.0 |
Erythrocytes/enzymology | 2 | 0.0 |
Gypsies/*genetics | 2 | 18.0 |
Slovakia | 2 | 9.0 |
Gene Frequency/genetics | 2 | 0.0 |
Lod Score | 4 | 0.0 |
Asian Continental Ancestry Group/*genetics | 2 | 0.0 |
*Variation (Genetics) | 4 | 0.0 |
*Carboxylesterase | 2 | 1.0 |
Africa/ethnology | 2 | 4.0 |
African Continental Ancestry Group/genetics | 3 | 1.0 |
European Continental Ancestry Group/genetics | 3 | 0.0 |
HLA Antigens/genetics | 4 | 1.0 |
Blood Proteins/analysis | 2 | 1.0 |
DNA Probes | 2 | 0.0 |
*Genetic Markers | 2 | 0.0 |
Linkage (Genetics) | 5 | 0.0 |
Pedigree | 8 | 0.0 |
*Linkage (Genetics) | 6 | 0.0 |
Recombination, Genetic | 5 | 0.0 |
Blood Group Antigens | 2 | 5.0 |
Brazil | 2 | 0.0 |
Immunoglobulin G/analysis | 2 | 0.0 |
India | 2 | 0.0 |
Mice | 2 | 0.0 |
Rats | 2 | 0.0 |
Age Factors | 2 | 0.0 |
*Lewis Blood-Group System | 2 | 25.0 |
Sex Factors | 3 | 0.0 |
*Blood Group Antigens | 5 | 9.0 |
